
|Articles|November 1, 2019 (Updated: November 15, 2020)
- Pharmaceutical Executive-11-01-2019
- Volume 39
- Issue 11
Pharmaceutical Executive, November 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Pharm Exec’s 2020 Pipeline Reportover 6 years ago
R. Jude Samulski: Gene Therapy’s Guiding Forceover 6 years ago
The Pace of Massive Innovationover 6 years ago
The Quest to Measure Drug Effectivenessover 6 years ago
Biosensors in Pharma: A Dose of Optimismover 6 years ago
Closing the Science and Manufacturing Divideover 6 years ago
Country Report: SwedenNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5




